STOCK TITAN

Helmerich & Payne, Inc. SEC Filings

HP NYSE

Welcome to our dedicated page for Helmerich & Payne SEC filings (Ticker: HP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Helmerich & Payne's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Helmerich & Payne's regulatory disclosures and financial reporting.

Rhea-AI Summary

Helmerich & Payne Inc: Amendment No. 16 to a Schedule 13G/A filed by The Vanguard Group reports 0 shares beneficially owned, representing 0% of the common stock.

The filing states that on January 12, 2026 The Vanguard Group underwent an internal realignment and will report certain subsidiaries or business divisions separately in reliance on SEC Release No. 34-39538; those subsidiaries pursue the same investment strategies previously followed. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Helmerich & Payne, Inc. senior vice president and chief legal officer Cara M. Hair reported an open-market sale of 58,771 shares of common stock at a weighted average price of $36.62 per share. Following this transaction, she directly holds 175,589 shares of Helmerich & Payne common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

HP filed a Form 144 reporting proposed sales of Common shares held by an affiliate. The filing lists multiple vested restricted stock lots tied to compensation, with example vesting entries including 16,109 shares (01/13/2023) and 19,280 shares (01/16/2025). The brokerage listed is Fidelity Brokerage Services LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Helmerich & Payne, Inc. is implementing a planned finance leadership transition alongside its recently appointed CEO. Senior Vice President and Chief Financial Officer Kevin Vann will retire from his CFO role effective June 30, 2026, and become a non-executive senior advisor through December 31, 2026.

The Board has appointed Todd Scruggs, currently Vice President, Corporate Finance and Treasurer, as Senior Vice President and Chief Financial Officer effective July 1, 2026. His annual base salary will be $475,000 with a target bonus equal to 90% of base salary for calendar 2026 starting July 1.

Under a Transition Services and Retirement Agreement, Vann will receive his current base salary through June 30, 2026, then an annual base salary of $309,000 as senior advisor through year-end and a one-time $750,000 bonus in lieu of a 2026 annual bonus, paid in two installments tied to the transition and his termination of employment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
current report
-
Rhea-AI Summary

Helmerich & Payne, Inc. reported results of its 2026 Annual Meeting of Stockholders held on March 4, 2026. Stockholders approved the Amended & Restated 2024 Omnibus Incentive Plan, a stock and cash-based plan covering options, stock awards, and cash incentives for officers, employees, consultants, and non-employee directors.

All nominated directors were elected to serve until the 2027 annual meeting. Stockholders also ratified the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending September 30, 2026 and approved, on an advisory basis, the compensation of the named executive officers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ZEGLIS JOHN D reported acquisition or exercise transactions in this Form 4 filing.

Helmerich & Payne, Inc. director John D. Zeglis reported receiving a grant of 5,273 shares of common stock, with a stated price of $0.00 per share. After this grant, his directly owned holdings increased to 73,442 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Helmerich & Payne, Inc. director Donald F. Robillard Jr. reported an acquisition of 5,273 units of phantom stock on March 5, 2026. The award was granted at a price of $0.00 per unit and increased his directly held phantom stock balance to 59,010 units.

The phantom shares relate to the company’s Director Deferred Compensation Plan on a 1-for-1 basis and are payable in cash only. Payment will occur either in a lump sum within 60 days after his board service ends or in annual installments for up to 10 years, at his election.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Killinger Elizabeth R reported acquisition or exercise transactions in this Form 4 filing.

Helmerich & Payne, Inc. director Elizabeth R. Killinger reported an equity award of 5,273 shares of common stock on March 5, 2026. This was a grant or similar award with a stated price of $0.00 per share, increasing her directly held common stock to 15,844 shares after the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

HELMERICH HANS reported acquisition or exercise transactions in this Form 4 filing.

Helmerich & Payne, Inc. director Hans Helmerich received a grant of 7,910 shares of common stock on March 5, 2026. The award was recorded at a price of $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase.

After this grant, his directly owned common stock increased to 138,009 shares. The filing also lists several indirect holdings in various trusts, a spouse account, a 401(k) account, and an LLC, showing additional share ownership through related entities as of the same date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Foutch Randy A reported acquisition or exercise transactions in this Form 4 filing.

Helmerich & Payne, Inc. director Randy A. Foutch reported receiving a grant of 5,273 shares of common stock on March 5, 2026. The award was recorded at a price of $0.00 per share, indicating it was a stock-based compensation grant rather than an open-market purchase. Following this grant, Foutch’s directly owned holdings increased to 35,897 shares of Helmerich & Payne common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Helmerich & Payne (HP) SEC filings are available on StockTitan?

StockTitan tracks 76 SEC filings for Helmerich & Payne (HP), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Helmerich & Payne (HP)?

The most recent SEC filing for Helmerich & Payne (HP) was filed on March 27, 2026.